HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea · Delayed Price · Currency is KRW 2,395.00
+155.00 (6.92%)
At close: Aug 11, 2026
HLB bioStep Market Cap
HLB bioStep has a market cap or net worth of 41.23 billion as of August 11, 2026. Its market cap has decreased by -62.37% in one year.
Market Cap
41.23B
Enterprise Value
45.97B
Revenue
73.96B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,395.00
ChartMarket Cap Chart
Since November 27, 2019, HLB bioStep's market cap has decreased from 254.44B to 41.23B, a decrease of -83.80%. That is a compound annual growth rate of -23.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 41.23B | -66.43% |
| Dec 30, 2025 | 122.82B | -30.37% |
| Dec 30, 2024 | 176.39B | -27.37% |
| Dec 28, 2023 | 242.88B | -25.95% |
| Dec 29, 2022 | 327.97B | 49.60% |
| Dec 30, 2021 | 219.23B | 14.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 241.51B |
| DreamCIS | 87.95B |
| P&K Skin Research Center | 52.65B |
| Kolmar BioTech | 39.72B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 23.51B |
| C&R Research | 22.14B |
| Curachem | 12.65B |